CMPR Cimpress
Cimpress earnings company data as of 4:45 AM ET 10/16
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.65 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CMPR's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $251K bought by 1 insider
- $9.3M sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Robert S Keane CEOSale$2.4M 28,000 shares at $84.89Traded Sep 11 Filed Sep 15
-
Robert S Keane CEOSale$625K 6,500 shares at $96.09 7.9% of stakeTraded Aug 11 Filed Aug 13
-
Sean Edward Quinn CFOSale$2.9M 27,989 shares at $104.54 49% of stakeTraded May 27–28 Filed May 29
-
Maarten Wensveen EVP & Chief Technology OfficerSale$1.8M 19,251 shares at $92.96 50% of stakeTraded May 5 Filed May 7
-
Sean Edward Quinn CFOBuy$251K 4,000 shares at $62.79 +12% to stakeTraded Nov 6, 2025 Filed Nov 7, 2025
-
Maarten Wensveen EVP & Chief Technology OfficerSale$1.6M 22,830 shares at $68.36 53% of stakeTraded Nov 3, 2025 Filed Nov 5, 2025
Also filed in the last 12 months, not counted as buying or selling: 74 option exercises and 24 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13D/A | — | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 2.02 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 1.01,2.01,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.